Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN5A | Q14524 | 1/20 | 0.33 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.31 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.30 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.30 |
| ▸ | CACNA1I | Q9P0X4 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25329828 | 0.91 | SCN5A (0.33) | SCN5ACACNA1GCACNA1HCACNA1I | |
| SCHEMBL30356486 | 0.89 | SCN5A (0.33) | SCN5ACACNA1GCACNA1HCACNA1I | |
| SCHEMBL25329836 | 0.87 | SCN5A (0.33) | SCN5ACACNA1GCACNA1HCACNA1I | |
| SCHEMBL25330293 | 0.86 | SCN5A (0.33) | SCN5ACACNA1GCACNA1HCACNA1I | |
| SCHEMBL25331313 | 0.85 | SCN5A (0.38) | SCN5A | |
| SCHEMBL25330737 | 0.84 | SCN5A (0.33) | SCN5ACACNA1GCACNA1HCACNA1I | |
| SCHEMBL25331693 | 0.83 | SCN5A (0.35) | SCN5ACACNA1GCACNA1HCACNA1I | |
| SCHEMBL25329094 | 0.81 | IMPDH2 (0.33) | ADRA1DADRA1AADRA1B | |
| SCHEMBL25328876 | 0.78 | — | — | |
| SCHEMBL25329481 | 0.78 | PTGS1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12583813-B2 | Polymerization inhibitors | BASF SE (DE) | 2026-03-24 | — | — | US | disclosed |
| US-20230242472-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2023-08-03 | — | — | US | disclosed |
| EP-4161892-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2023-04-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242472-A1 | POLYMERIZATION INHIBITORS | RCE1, CABLES1, DPYD | SCN5A 4507/4885ADRA1D 4718/4885ADRA1A 4695/4885 |
| US-12583813-B2 | Polymerization inhibitors | PTGS1, PTGER1, POT1 | SCN5A 4630/4885ADRA1D 324/4885ADRA1A 763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.